Suzhou Canimble Biotechnology Co., Ltd., located in the High-tech Venture Park in Zhangjiagang, is an innovate enterprise specializing in CRO service in the biological pharmaceutical field. Relying on Zhangjiagang high level innovate imbark talents project, our company is established by doctors and masters from famous international and domestic universities, and invites a postdoctor from American Harvard University and MGH to be the technical consultant. At present, our company owns 500 square meters standardized labs and standardized workshops that can produce hundreds kilograms of products, and is equipped with various chemical analysis instruments, such as GC，HPLC，LC-MS and so on, so we can offer international and domestic customs the whole service from researching to producing.
Our company has independent and innovate technology in the heterocycle field, such as a series of pyrimidine, pyridine, quinazoline, quinoline, benzene ring etc. ,and also has mass production on the manufacture terrace. In the field of pharmaceutical products, we have systematically researched small molecular targeted anticancer drugs-tinib series, antidiabetic drugs-gliptins series, antihypertensive drugs-Sartan series, many of which have finished Scale-up experiments .We are looking forward to having a good cooperation with global biological pharmaceutical enterprises,new drug R&D institutions and pharmaceutical intermediate traders.